The Regulatory 2.0 track is a two-day intensive program that will prepare leaders in medtech to manage through the evolving landscape at the FDA and abroad with the new EU-MDR.
Changes in regulatory landscape have a material impact on how biologics, drugs and medical devices get to market, this course will bring you up to speed on everything you need to know about what is evolving in the global regulator landscape. Day One will concentrate on changes domestically at the FDA and Day Two will feature an immersive curriculum on everything you need to know about how the new EU MDR will impact our industry. This content is brought to you by experts at R&Q.
The Regulatory 2.0 program, which has been a mainstay in the Twin Cities for the past 20 years, has been brought to DeviceTalks through a partnership with Medical Alley Association and curated by some of the top minds in the regulatory landscape.
When you register for Regulatory 2.0 you will also gain full access to the entire DeviceTalks program, taking place June 4-5, 2018.
Register using the code “Reg2” to take advantage of a special discount.
Regulatory 2.0 Featured Sessions
Monday, June 4, 2018 – Tuesday, June 5, 2018